Bradford Crutchfield - Net Worth and Insider Trading
Bradford Crutchfield Net Worth
The estimated net worth of Bradford Crutchfield is at least $4 Million dollars as of 2024-05-20. Bradford Crutchfield is the Chief Commercial Officer of 10x Genomics Inc and owns about 97,237 shares of 10x Genomics Inc (TXG) stock worth over $2 Million. Bradford Crutchfield is also the Vice President of Bio-Rad Laboratories Inc and owns about 6,023 shares of Bio-Rad Laboratories Inc (BIO) stock worth over $2 Million. Details can be seen in Bradford Crutchfield's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bradford Crutchfield has not made any transactions after 2022-05-23 and currently still holds the listed stock(s).
Transaction Summary of Bradford Crutchfield
Bradford Crutchfield Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bradford Crutchfield owns 3 companies in total, including 10x Genomics Inc (TXG) , Bio-Rad Laboratories Inc (BIO) , and NanoString Technologies Inc (NSTGQ) .
Click here to see the complete history of Bradford Crutchfield’s form 4 insider trades.
Insider Ownership Summary of Bradford Crutchfield
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TXG | 10x Genomics Inc | 2022-05-23 | Chief Commercial Officer |
| BIO | Bio-Rad Laboratories Inc | 2012-09-10 | Vice President |
| NSTGQ | NanoString Technologies Inc | 2013-06-25 | director |
Bradford Crutchfield Latest Holdings Summary
Bradford Crutchfield currently owns a total of 2 stocks. Among these stocks, Bradford Crutchfield owns 97,237 shares of 10x Genomics Inc (TXG) as of May 23, 2022, with a value of $2 Million and a weighting of 57.87%. Bradford Crutchfield also owns 6,023 shares of Bio-Rad Laboratories Inc (BIO) as of September 10, 2012, with a value of $2 Million and a weighting of 42.13%.
Latest Holdings of Bradford Crutchfield
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TXG | 10x Genomics Inc | 2022-05-23 | 97,237 | 24.83 | 2,414,395 |
| BIO | Bio-Rad Laboratories Inc | 2012-09-10 | 6,023 | 291.88 | 1,757,993 |
Holding Weightings of Bradford Crutchfield
Bradford Crutchfield Form 4 Trading Tracker
According to the SEC Form 4 filings, Bradford Crutchfield has made a total of 28 transactions in 10x Genomics Inc (TXG) over the past 5 years, including 1 buys and 27 sells. The most-recent trade in 10x Genomics Inc is the sale of 286 shares on May 23, 2022, which brought Bradford Crutchfield around $13,945.
According to the SEC Form 4 filings, Bradford Crutchfield has made a total of 0 transactions in Bio-Rad Laboratories Inc (BIO) over the past 5 years. The most-recent trade in Bio-Rad Laboratories Inc is the sale of 92 shares on September 10, 2012, which brought Bradford Crutchfield around $9,521.
Insider Trading History of Bradford Crutchfield
- 1
Bradford Crutchfield Trading Performance
GuruFocus tracks the stock performance after each of Bradford Crutchfield's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bradford Crutchfield is 1.28%. GuruFocus also compares Bradford Crutchfield's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bradford Crutchfield within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bradford Crutchfield's insider trading performs compared to the benchmark.
Performance of Bradford Crutchfield
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -22.42 | | | | | |
| Relative Return to S&P 500(%) | -15.6 | | | | | |
Bradford Crutchfield Ownership Network
Bradford Crutchfield Owned Company Details
What does 10x Genomics Inc do?
Who are the key executives at 10x Genomics Inc?
Bradford Crutchfield is the Chief Commercial Officer of 10x Genomics Inc. Other key executives at 10x Genomics Inc include director & 10 percent owner & Chief Executive Officer Serge Saxonov , director & See Remarks Benjamin J. Hindson , and Chief Financial Officer Justin J. Mcanear .
10x Genomics Inc (TXG) Insider Trades Summary
Over the past 18 months, Bradford Crutchfield made no insider transaction in 10x Genomics Inc (TXG). Other recent insider transactions involving 10x Genomics Inc (TXG) include a net sale of 90,937 shares made by Serge Saxonov , a net sale of 36,912 shares made by Benjamin J. Hindson , and a net sale of 9,758 shares made by Justin J. Mcanear .
In summary, during the past 3 months, insiders sold 11,959 shares of 10x Genomics Inc (TXG) in total and bought 0 shares, with a net sale of 11,959 shares. During the past 18 months, 208,804 shares of 10x Genomics Inc (TXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 208,804 shares.
10x Genomics Inc (TXG)'s detailed insider trading history can be found in Insider Trading Tracker table.
10x Genomics Inc Insider Transactions
Bradford Crutchfield Mailing Address
Above is the net worth, insider trading, and ownership report for Bradford Crutchfield. You might contact Bradford Crutchfield via mailing address: 6230 Stoneridge Mall Road, Pleasanton Ca 94547.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
